Dewpoint Therapeutics and ConcertAI Announce the First Phase of their Translational Oncology Partnership
Supporting Dewpoint’s novel condensate modulating approach to drug previously ‘undruggable’ therapeutic targets, guided by ...
BioPharma Dive9d
Dewpoint, Mitsubishi partner on ALS drug in deal worth up to $480M
The collaboration is another vote of confidence in Dewpoint’s biomolecular condensates research, which had already attracted ...
BioWorld6d
Dewpoint and Mitsubishi ink $480M ALS research collaboration
Dewpoint Therapeutics Inc. and Mitsubishi Tanabe Pharma Corp. have entered a research collaboration worth up to $480 million ...
FierceBiotech9d
Mitsubishi Tanabe inks $480M biobucks pact with Dewpoint for preclinical ALS program
Mitsubishi Tanabe Pharma is offering Dewpoint Therapeutics up to $480 million biobucks in a new research pact centering ...
GlobalData on MSN8d
Dewpoint Therapeutics and Mitsubishi Tanabe link on ALS treatment
Dewpoint Therapeutics CEO Ameet Nathwani stated: “This partnership underscores the transformative potential of our small ...
Outsourcing-pharma8d
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
The Pharma Letter9d
Dewpoint and Mitsubishi Tanabe to advance small molecule condensate modulator for ALS
Privately-held Dewpoint Therapeutics, a Boston, USA, biotech developing therapeutics by targeting biomolecular condensates, ...
Evening Forecast – Thursday, December 12th
Tonight, low temperatures are back into the mid to upper 30s. Dewpoint temperatures are on the rise now that winds have ...
manilatimes9d
Dewpoint Therapeutics and Mitsubishi Tanabe Pharma Corporation Enter Research Collaboration to Advance Small Molecule Condensate Modulator for ALS
Under the terms of the agreement, Dewpoint will receive an upfront payment and will be eligible for milestone payments based on specified near-term research and development objectives, with a total ...